94 related articles for article (PubMed ID: 8965477)
1. [Band-like keratopathy after treatment of postoperative fibrin reaction with tissue plasminogen activator].
Wollensak G; Meyer JH; Löffler KU; Funk J
Klin Monbl Augenheilkd; 1996 Jul; 209(1):43-6. PubMed ID: 8965477
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
Schmitz K; Greite JH; Bartenschlager EM
Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
[TBL] [Abstract][Full Text] [Related]
3. [Acute band-shaped keratopathy after intraocular fibrinolysis with recombinant tissue plasminogen activator (rt-PA)].
Althaus C; Schelle C; Sundmacher R
Klin Monbl Augenheilkd; 1996 Nov; 209(5):318-21. PubMed ID: 9044983
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
[TBL] [Abstract][Full Text] [Related]
5. [Etiology of corneal opacities after plasminogen activator-induced fibrinolysis of the anterior chamber].
Hesse L; Nebeling B; Kauffmann T
Ophthalmologe; 1999 Jul; 96(7):448-52. PubMed ID: 10479896
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
Heiligenhaus A; Schilling H; Schilling M; Mellin KB
Ophthalmologe; 1996 Feb; 93(1):49-53. PubMed ID: 8867161
[TBL] [Abstract][Full Text] [Related]
7. Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis.
Wu TT; Wang HH
Eye (Lond); 2009 Jan; 23(1):101-7. PubMed ID: 17901882
[TBL] [Abstract][Full Text] [Related]
8. [Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].
Oficjalska-Młyńczak J; Marek J; Zajac-Pytrus H; Nizankowska MH; Koziorowska M
Klin Oczna; 1996; 98(6):423-5. PubMed ID: 9340414
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
Koerner F; Boehnke M
Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic and prophylactic application of TPA (recombinant tissue plasminogen activator) into the anterior chamber of the eye].
Rehfeldt K; Höh H
Ophthalmologe; 1999 Sep; 96(9):587-93. PubMed ID: 10501987
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation].
Xie L; Li S; Dong X; Cao J; Shi W; Guo P
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):291-3. PubMed ID: 11877211
[TBL] [Abstract][Full Text] [Related]
12. Intracameral fibrin tissue sealant as an adjunct in tectonic lamellar keratoplasty for large corneal perforations.
Por YM; Tan YL; Mehta JS; Tan DT
Cornea; 2009 May; 28(4):451-5. PubMed ID: 19411966
[TBL] [Abstract][Full Text] [Related]
13. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
Dotan A; Kaiserman I; Kremer I; Ehrlich R; Bahar I
Br J Ophthalmol; 2014 Feb; 98(2):252-5. PubMed ID: 24276695
[TBL] [Abstract][Full Text] [Related]
14. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
[TBL] [Abstract][Full Text] [Related]
15. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery.
Murray TG; Jaffe GJ; McKay BS; Han DP; Burke JM; Abrams GW
Refract Corneal Surg; 1992; 8(1):44-8; discussion 48-53. PubMed ID: 1554639
[TBL] [Abstract][Full Text] [Related]
16. Rapid development of band keratopathy of corneal graft associated with treatment with intracameral recombinant tissue plasminogen activator for postoperative fibrin reaction.
Spitzer MS; Szurman P; Aisenbrey S; Rohrbach JM
Eur J Ophthalmol; 2007; 17(3):433-6. PubMed ID: 17534830
[TBL] [Abstract][Full Text] [Related]
17. Sonothrombolysis for intraocular fibrin formation in an animal model.
Yamashita T; Ohtsuka H; Arimura N; Sonoda S; Kato C; Ushimaru K; Hara N; Tachibana K; Sakamoto T
Ultrasound Med Biol; 2009 Nov; 35(11):1845-53. PubMed ID: 19699025
[TBL] [Abstract][Full Text] [Related]
18. Use of tissue plasminogen activator for intraocular fibrinolysis in dogs.
Gerding PA; Essex-Sorlie D; Vasaune S; Yack R
Am J Vet Res; 1992 Jun; 53(6):894-6. PubMed ID: 1626779
[TBL] [Abstract][Full Text] [Related]
19. Acute calcific band keratopathy: case report and literature review.
Moisseiev E; Gal A; Addadi L; Caspi D; Shemesh G; Michaeli A
J Cataract Refract Surg; 2013 Feb; 39(2):292-4. PubMed ID: 23332257
[TBL] [Abstract][Full Text] [Related]
20. Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin.
Zwaan J; Latimer WB
Ophthalmic Surg Lasers; 1998 Jun; 29(6):476-83. PubMed ID: 9640569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
